Altera Biosciences is a South African startup pioneering cell and gene therapy in Africa, co-founded by Alexandra Miszewski and Professor Michael Pepper. The company is developing a universal donor cell platform that aims to make donor cells invisible to patients' immune systems using gene silencing. Target applications include organ transplantation and treatments for diabetes and cancer. Altera positions Africa's genetic diversity as a unique R&D advantage and seeks to build therapies with global relevance while ensuring access in Africa. Financially, the company completed a ZAR 29 million (≈USD 1.6 million) pre-seed raise. The round was backed by investors including OneBio and E Squared Investments.

Total raised

$2M

Funding rounds

1

Latest round

Seed

Latest activity

Aug 2025